// App-Quantinova.ai

3104 : Sequential Analysis of miRNA Profiling during Azacitidine and Lenalidomide Therapy in Myelodysplastic Syndromes

Researchers

Presenter

  • Matilde Y Follo

Principal Investigators

  • Sara Mongiorgi

  • Alessia De Stefano

  • Valentina Indio

  • Annalisa Astolfi

  • Andrea Pellagatti

  • Stefano Ratti

  • Miriam Fogli

  • Sarah Parisi

  • Andrea Pession

  • Michele Cavo

  • Lucia Manzoli

  • Lucio Cocco

  • Jacqueline Boultwood

  • Carlo Finelli

Medical Centers

  • Department of Biomedical and Neuromotorial Sciences, Alma Mater University, Bologna, Italy

  • Interdepartmental Centre of Cancer Research "G. Prodi", University of Bologna, Bologna, Italy, Bologna, Italy

  • Dipartimento di Morfologia, chirurgia e medicina sperimentale, University of Ferrara, Ferrara, Italy

  • Bloodwise Molecular Haematology Unit, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom

  • DIMES - Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology, University of Bologna, Bologna, Italy

  • Sant'Orsola-Malpighi Hospital, "Lalla Seràgnoli" Institute, Bologna, Italy

  • Institute of Hematology, University of Bologna, Bologna, Italy

Locations

  • Italy

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Myelodysplastic Syndrome

Biomarkers

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

Drug/Treatment

  • Lenalidomide

  • Vidaza

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved